Emerging Topics in Cardiometabolic and Psychological Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review

    July 2019 in “ Children (Basel)
    Rachana Shah
    Image of study
    TLDR The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.
    The 2019 review addressed the multifaceted nature of Polycystic Ovarian Syndrome (PCOS), affecting 6-10% of women of reproductive age, and its impact on various health aspects including reproductive, metabolic, dermatologic, and psychiatric health. It emphasized the unknown pathogenesis of PCOS and the focus on symptom management for treatment. The review covered the diagnostic criteria for PCOS, such as the Rotterdam criteria, and management strategies that include regulating menstrual cycles and addressing mental health issues. It also discussed the cardiometabolic risks like insulin resistance and mood disorders associated with PCOS. Advances in understanding the role of the gut microbiome, genetic and epigenetic factors in PCOS were mentioned, along with novel treatments being explored, including diabetes medications and nutritional supplements. The review concluded that despite progress, further research is essential for improving the long-term health outcomes for individuals with PCOS.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 12 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Bryan Johnson just dropped his anti hair loss formula

      in Treatment  339 upvotes 9 months ago
      Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.

      community having hair loss as a teen SUCKS. A LOT.

      in Female  12 upvotes 2 years ago
      A teenage girl who has been diagnosed with ADA and is struggling with hair loss, which has caused her to lose confidence. She is looking for recommendations on treatments such as finasteride or Minoxidil, and lifestyle advice including vitamins and other supplements that might help with the issue.

      community My scalp punch biopsy results🤔?

      in Female  8 upvotes 1 year ago
      Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.

    Similar Research

    5 / 1000+ results